
Eric Drapé
Executive Vice President, Global Operations
Eric Drapé joined Teva in 2014 and became Executive Vice President and Chief Quality Officer of the Teva Group in 2015, leading operations for one of the largest manufacturing networks in the pharma industry.
The Teva Global Operations (TGO) team contributes to Teva’s performance by supporting the execution of new product launches while consistently driving cost savings and improvements in efficiencies, competitiveness and service across the global manufacturing network and supply chain.
Prior to this role, Eric Drapé served in various senior management positions, notably heading up Teva's Biologics Operations and as Senior Vice President of Technical Operations Steriles, Respiratory and Biologics.
Before joining Teva, he managed Technical Operations for Ipsen Pharma and served in several leading positions at Novo Nordisk.
Eric holds a Pharm.D and a DESS in Analytical Control of Drugs from the Université Paris XI. He also received his Executive MBA from the Scandinavian International Management Institute in Copenhagen.

Richard Francis
President and Chief Executive Officer, Member of the Board of Directors

Dov P. Bergwerk
Acting Chief Legal Officer & Corporate Secretary

Vikki Conway
Acting Head of Global Human Resources

Richard Daniell
Executive Vice President, European Commercial

Christine Fox
Executive Vice President, U.S. Commercial

Angus J. Grant, PhD
Executive Vice President, Business Development

Dr. Eric A. Hughes
Executive Vice President, Global R&D and Chief Medical Officer

Eli Kalif
Executive Vice President, Chief Financial Officer (CFO)

Mark Sabag
Executive Vice President, International Markets Commercial

Nir Baron
Senior Vice President, Chief Internal Auditor

Kathleen Veit
Senior Vice President, Global Compliance & Ethics Officer
At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:
Copyright © 2023 Teva Pharmaceutical Industries Ltd.